High-level oxacillin and gentamycin resistance with reduced susceptibility to vancomycin in Staphylococcus aureus-carrying mecA and femA gene complex

Current Microbiology

Volumn 54, Issue 6, 2007, Pages 429-434

  Raju, S ^a   Kelmani Chandrakanth, R ^a   Patil, S A ^b  

^a GULBARGA UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG POTENTIATION; FEMA GENE; GENOME ANALYSIS; MECA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIAL PROTEINS; BETA-LACTAMASES; CELL WALL; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENTAMICINS; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OXACILLIN; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

STAPHYLOCOCCUS AUREUS;

EID: 34249049252     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-006-0584-6     Document Type: Article

References (25)

1. Anandi C, Alaguraja D, Natarajan V, et al. (2004) Bacteriology of Diabetic foot lesions. Indian J Med Microbiol 22 (3):175-178
2. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM (2003) Prevalence of methicillin resistant Staphylococcus aureus a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 21:49-51
3. Aritaka N, Hanaki H, Cui L, Hiramatsu K (2001) Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrob Agents Chemother 45:1292-1294
4. Bagdade JD, Root RK, Bulger RD (1974) Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 23:9-15
5. Cooper G, Platt R (1982) Staphylococcus aureus bacteremia in diabetic patients: Endocarditis and mortality. Am J Med 73:658-662
6. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin resistant and methicillin susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53-59
7. Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K (2000 ) Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother 44:2276-2285
8. Cui L, Ma X, Sato K, et al. (2003) Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 41:5-14
9. Dang CN, Prasad YDM, Boulton AJM, Jude EB (2002) Methicillin resistant Staphylococcus aureus in the diabetic foot clinic: the problem is getting worse. Diabetologia 45:A4
10. Fani R, Damiani G, Di Serio Gallori E, Grifoni A, Bazzicalupo M (1993) Use of random amplified polymorphic DNA (RAPD) for generating specific DNA probes for microorganisms. Mol Ecol 2:243-250
11. Franklin D, Lowy MD (1998) Staphylococcus aureus infections. N Engl J Med 339(8):520-532
12. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K (1998) Activated cell wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 42:199-209
13. Hartman BJ, Tomasz A (1984) Low affinity penicillin binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bactriol 158:513-516
14. Hiramatsu K, Hanaki H, Ito T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135-136
15. Hiramatsu K, Cui L, Kuroda M, Ito T (2001) The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 9:486-493
16. Houlihan HH, Mercier RC, Rybak MJ (1997) Pharmacodynamics of vancomycin alone and in combination with gentamycin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin platelet clots in an in vitro infection model. Antimicrob Agent Chemother 41:2497-2501
17. NCCLS (2000) National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Disk Susceptibility Test, 7th ed. Approved Standard M2-A7. NCCLS, Villanova, PA
18. O'Brien IAD, Corrall RJM (1988) Epidemiology of diabetes and its complications. N Engl JMed 318:1619-1620
19. Oliveira DC, de Lencastre H (2002) Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin resistant Staphylococcus aureus. Antimicrob Agents Chemother 46:2155-2161
20. Saulnier P, Bourneix C, Prevost G, Andremont A (1993) Random amplified polymorphic DNA assay is less discriminant than pulsed-field gel electrophoresis for typing strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 31:982-985
21. Sieradzki K, Roberts RB, Haber SW, Tomasz A (1999) The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 340:517-523
22. Small PM, Chambers HF (1990) Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 34:1227-1231
23. Song JH, Hiramatsu K, Suh JY, et al. (2004) Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agent Chemother 48:4926-4928
24. Takashi I, Ryoichi O, Chieko S, Toyoji O, Akio K, Matsuhisa I (2001) Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J Clin Microbiol 39:3115-3121
25. Weller TMA (1999) The distribution of mecA, mecR1 and mecl and sequence analysis of mecl and the promotor region in Staphylococci expressing resistance to methicillin. J Antimicrob Chemother 43:15-22